Mendelian Randomization Indicates a Causal Role for Omega-3 Fatty Acids in Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) is characterized by chronic inflammation of the gastrointestinal system. Omega-3 (ω<sub>3</sub>) fatty acids are polyunsaturated fatty acids (PUFAs) that are largely obtained from diet and have been speculated to decrease the inflammatory response that is...

Full description

Bibliographic Details
Main Authors: Courtney Astore, Sini Nagpal, Greg Gibson
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/22/14380
_version_ 1797465010770804736
author Courtney Astore
Sini Nagpal
Greg Gibson
author_facet Courtney Astore
Sini Nagpal
Greg Gibson
author_sort Courtney Astore
collection DOAJ
description Inflammatory bowel disease (IBD) is characterized by chronic inflammation of the gastrointestinal system. Omega-3 (ω<sub>3</sub>) fatty acids are polyunsaturated fatty acids (PUFAs) that are largely obtained from diet and have been speculated to decrease the inflammatory response that is involved in IBD; however, the causality of this association has not been established. A two-sample Mendelian randomization (MR) was used to assess genetic associations between 249 circulating metabolites measured in the UK Biobank as exposures and IBD as the outcome. The genome-wide association study summary level data for metabolite measurements and IBD were derived from large European ancestry cohorts. We observed ω<sub>3</sub> fatty acids as a significant protective association with IBD, with multiple modes of MR evidence replicated in three IBD summary genetic datasets. The instrumental variables that were involved in the causal association of ω<sub>3</sub> fatty acids with IBD highlighted an intronic SNP, rs174564, in <i>FADS2</i>, a protein engaged in the first step of alpha-linolenic acid desaturation leading to anti-inflammatory EPA and thence DHA production. A low ratio of ω<sub>3</sub> to ω<sub>6</sub> fatty acids was observed to be a causal risk factor, particularly for Crohn’s disease. ω<sub>3</sub> fatty acid supplementation may provide anti-inflammatory responses that are required to attenuate inflammation that is involved in IBD.
first_indexed 2024-03-09T18:15:23Z
format Article
id doaj.art-0f8e721bb07d4608823b5e121040b8ef
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T18:15:23Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-0f8e721bb07d4608823b5e121040b8ef2023-11-24T08:43:22ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-11-0123221438010.3390/ijms232214380Mendelian Randomization Indicates a Causal Role for Omega-3 Fatty Acids in Inflammatory Bowel DiseaseCourtney Astore0Sini Nagpal1Greg Gibson2Center for Integrative Genomics, School of Biological Sciences, Georgia Institute of Technology, Krone EBB1 Building, 950 Atlantic Drive, Atlanta, GA 30332, USACenter for Integrative Genomics, School of Biological Sciences, Georgia Institute of Technology, Krone EBB1 Building, 950 Atlantic Drive, Atlanta, GA 30332, USACenter for Integrative Genomics, School of Biological Sciences, Georgia Institute of Technology, Krone EBB1 Building, 950 Atlantic Drive, Atlanta, GA 30332, USAInflammatory bowel disease (IBD) is characterized by chronic inflammation of the gastrointestinal system. Omega-3 (ω<sub>3</sub>) fatty acids are polyunsaturated fatty acids (PUFAs) that are largely obtained from diet and have been speculated to decrease the inflammatory response that is involved in IBD; however, the causality of this association has not been established. A two-sample Mendelian randomization (MR) was used to assess genetic associations between 249 circulating metabolites measured in the UK Biobank as exposures and IBD as the outcome. The genome-wide association study summary level data for metabolite measurements and IBD were derived from large European ancestry cohorts. We observed ω<sub>3</sub> fatty acids as a significant protective association with IBD, with multiple modes of MR evidence replicated in three IBD summary genetic datasets. The instrumental variables that were involved in the causal association of ω<sub>3</sub> fatty acids with IBD highlighted an intronic SNP, rs174564, in <i>FADS2</i>, a protein engaged in the first step of alpha-linolenic acid desaturation leading to anti-inflammatory EPA and thence DHA production. A low ratio of ω<sub>3</sub> to ω<sub>6</sub> fatty acids was observed to be a causal risk factor, particularly for Crohn’s disease. ω<sub>3</sub> fatty acid supplementation may provide anti-inflammatory responses that are required to attenuate inflammation that is involved in IBD.https://www.mdpi.com/1422-0067/23/22/14380polygenic riskCrohn’s diseasedocasahexaenoic acidUK BioBank
spellingShingle Courtney Astore
Sini Nagpal
Greg Gibson
Mendelian Randomization Indicates a Causal Role for Omega-3 Fatty Acids in Inflammatory Bowel Disease
International Journal of Molecular Sciences
polygenic risk
Crohn’s disease
docasahexaenoic acid
UK BioBank
title Mendelian Randomization Indicates a Causal Role for Omega-3 Fatty Acids in Inflammatory Bowel Disease
title_full Mendelian Randomization Indicates a Causal Role for Omega-3 Fatty Acids in Inflammatory Bowel Disease
title_fullStr Mendelian Randomization Indicates a Causal Role for Omega-3 Fatty Acids in Inflammatory Bowel Disease
title_full_unstemmed Mendelian Randomization Indicates a Causal Role for Omega-3 Fatty Acids in Inflammatory Bowel Disease
title_short Mendelian Randomization Indicates a Causal Role for Omega-3 Fatty Acids in Inflammatory Bowel Disease
title_sort mendelian randomization indicates a causal role for omega 3 fatty acids in inflammatory bowel disease
topic polygenic risk
Crohn’s disease
docasahexaenoic acid
UK BioBank
url https://www.mdpi.com/1422-0067/23/22/14380
work_keys_str_mv AT courtneyastore mendelianrandomizationindicatesacausalroleforomega3fattyacidsininflammatoryboweldisease
AT sininagpal mendelianrandomizationindicatesacausalroleforomega3fattyacidsininflammatoryboweldisease
AT greggibson mendelianrandomizationindicatesacausalroleforomega3fattyacidsininflammatoryboweldisease